False Positives Will Not Upset People in Lung Cancer Screening
Allaying the fears of policymakers in the US who are worried that high rates of false positive results in computerized tomography (CT) lung screening for cancer may upset people, an analysis of...
View ArticleLung Cancer Diagnosis Tool Safe and Effective for Older Patients
A study in Manchester has found that a procedure to take tissue samples from lung cancer patients can be used safely in the elderly - allowing doctors to make an accurate diagnosis and to choose...
View ArticleUS Lung Cancer Rates Vary by Subtype, Sex, Race, Age
US lung cancer rates are declining overall, confirms a new analysis. But it also uncovers previously unrecognized trends related to cancer subtype, sex, race/ethnicity, and age. Published early online...
View ArticleResearch: High Concordance Between EGFR Mutations from Circulating-Free...
New research suggests that there is a high degree of correlation between epidermal growth factor receptor (EGFR) mutations found in the circulating free tumor DNA (ctDNA) from the plasma of advanced...
View ArticleScientists Find Potential Method to Control Lung Cancer Using Radiotherapy
Manchester scientists are working out how to safely increase the radiotherapy dose given to lung cancer patients - potentially offering improved local control and survival for the patients. Standard...
View ArticleMicroRNA Combination Therapy Offers Potential Therapeutic Avenue for Lung...
Researchers have found that a combination therapy involving two miRNAs, let-7 and miR-34, suppressed tumor growth in an animal model of non-small-cell lung cancer. This finding can provide new...
View ArticleStudy Looks into Benefits of Covering Lung Cancer Screening for Medicare...
Centers for Medicare and Medicaid Services (CMS) researchers are currently investigating whether there is any evidence that provides a better understanding about the benefits or harm of conducting...
View ArticleLung Cancer can be Identified by Breath Temperature Test
A new study says that the temperature of exhaled breath could be used to diagnose lung cancer. The research, presented at the European Respiratory Society (ERS) International Congress in Munich today...
View ArticleSome Lung Cancer Patients Could Live Longer When Treated
A new research presented at ASTRO's 2014 Annual Meeting revealed that treating advanced small-cell lung cancer (SCLC) with thoracic (or chest) radiation therapy in addition to standard treatment...
View ArticlePromising Therapies for Small Cell Lung Cancer Highlighted in Research
A research team at University Hospitals (UH) Case Medical Center Seidman Cancer Center has recently published two studies that have the potential to advance treatments for small cell lung cell cancer...
View ArticleROS1-Positive Lung Cancer may Respond to Crizotinib Treatment
New research has indicated that treatment with the targeted therapy drug crizotinib stops the growth of lung tumors that developed due to rearrangements of the ROS1 gene. In an article receiving...
View ArticleContinuing Tyrosine Kinase Inhibitor Therapy After Resistance Development in...
A phase III trial has shown that patients whose lung cancer has developed resistance to the drug gefitinib experience no statistically significant improvement in progression-free survival from...
View ArticleNew Findings on Treatment Options for Mesothelioma
Treating patients with high-dose radiotherapy after chemotherapy and surgery for malignant pleural mesothelioma does not achieve improvements in local relapse and overall survival. This is according...
View ArticleTargeted Approaches to Certain Lung Cancer Show Promising Results
After chemotherapy disease progresses in some of the patients with advanced BRAF V600E mutant non-small cell lung cancer. The BRAF inhibitor dabrafenib was found to have significant anti-tumour...
View ArticlePemetrexed or Docetaxel With Cisplatin Achieve Comparable Outcomes in...
The comparison of treating non-squamous lung cancer with either pemetrexed or docetaxel in addition to cisplatin has shown that the two combinations achieve similar progression-free survival. Although...
View ArticleLung Cancer can Lie Dormant for Two Decades, Says Study
Lung cancers can lie dormant for over 20 years before suddenly turning into an aggressive form of the disease, a new study has suggested. According to the study by cancer research UK on seven patients...
View ArticleReport Suggests Nearly 1 in 3 UK Lung Cancer Patients Dies Within 3 Months...
A new study suggests that almost 1 in 3 patients with lung cancer dies within three months of diagnosis in the UK. The findings suggest that family doctors may not be picking up the signs of lung...
View ArticleBlood Biomarker to Help Spot Lung Cancer
With help of a blood biomarker, doctors may very soon be able to detect lung cancer early in its stage. A new study has shown that patients with stage I to stage III non-small cell lung cancer have...
View ArticleSelf-destruct Switch in Lung Cancer Cells Triggered
A drug combination that can trigger the self-destruct process in lung cancer cells has been discovered by UK scientists. When healthy cells are no longer useful they initiate a chain of events...
View ArticleCombination Drug to Set Off Self-destruct Process in Lung Cancer Cells...
A combination drug that can set off the self-destruct process in lung cancer cells has been discovered. Using lung cancer cells and mice the Cancer Research UK team, based at the UCL Cancer Institute...
View Article